The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Use of Surveillance for Hepatocellular Carcinoma Among Patients With Cirrhosis in the United States
Open accessAbstract
Surveillance for hepatocellular carcinoma (HCC) in patients with cirrhosis is recommended but may not be performed. The extent and determinants of HCC surveillance are unknown. We conducted a population-based United States cohort study of patients over 65 years of age to examine use and determinants of prediagnosis surveillance in patients with HCC who were previously diagnosed with cirrhosis. Patients diagnosed with HCC during 1994-2002 were identified from the linked Surveillance, Epidemiology, and End-Results registry–Medicare databases. We identified alpha-fetoprotein (AFP) and ultrasound tests performed for HCC surveillance, and examined factors associated with surveillance. We identified 1,873 HCC patients with a prior diagnosis of cirrhosis. In the 3 years before HCC, 17% received regular surveillance and 38% received inconsistent surveillance. In a subset of 541 patients in whom cirrhosis was recorded for 3 or more years prior to HCC, only 29% received routine surveillance and 33% received inconsistent surveillance. Among all patients who received regular surveillance, approximately 52% received both AFP and ultrasound, 46% received AFP only, and 2% received ultrasound only. Patients receiving regular surveillance were more likely to have lived in urban areas and had higher incomes than those who did not receive surveillance. Before diagnosis, approximately 48% of patients were seen by a gastroenterologist/hepatologist or by a physician with an academic affiliation; they were approximately 4.5-fold and 2.8-fold, respectively, more likely to receive regular surveillance than those seen by a primary care physician only. Geographic variation in surveillance was observed and explained by patient and physician factors. Conclusion: Less than 20% of patients with cirrhosis who developed HCC received regular surveillance. Gastroenterologists/hepatologists or physicians with an academic affiliation are more likely to perform surveillance. Hepatology 2010
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1990) · Choice Reviews Online · doi:10.5860/choice.27-3338 · Cited by 35,305
The Varimax Criterion for Analytic Rotation in Factor Analysis
Kaiser, H. F. (1958) · Psychometrika · doi:10.1007/bf02289233 · Cited by 7,580
Management of Hepatocellular Carcinoma *
Bruix, J., & Sherman, M. (2005) · Hepatology · doi:10.1002/hep.20933 · Cited by 5,857
Harman, H. H. (1960) · Cited by 5,148
Clinical Management of Hepatocellular Carcinoma. Conclusions of the Barcelona-2000 EASL Conference
Bruix, J., Sherman, M., Llovet, J. M., Beaugrand, M., Lencioni, R., Burroughs, A. K., Christensen, E., Pagliaro, L., Colombo, M., & Rodés, J. (2001) · Journal of Hepatology · doi:10.1016/s0168-8278(01)00130-1 · Cited by 4,089
Warren, J. L., Klabunde, C. N., Schrag, D., Bach, P. B., & Riley, G. F. (2002) · PubMed · doi:10.1097/01.mlr.0000020942.47004.03 · Cited by 1,714
Randomized controlled trial of screening for hepatocellular carcinoma
Zhang, B.-H., Yang, B.-H., & Tang, Z.-Y. (2004) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-004-0552-0 · Cited by 1,496
The Continuing Increase in the Incidence of Hepatocellular Carcinoma in the United States: An Update
El-Serag, H. B., Davila, J. A., Petersen, N. J., & McGlynn, K. A. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-139-10-200311180-00009 · Cited by 943
Self-citationDavila, J. A., Morgan, R. O., Shaib, Y., McGlynn, K. A., & El–Serag, H. B. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.07.020 · Cited by 501
Self-citationGuidelines for the diagnosis and treatment of hepatocellular carcinoma (HCC) in adults
Ryder, S. D. (2003) · Gut · doi:10.1136/gut.52.suppl_3.iii1 · Cited by 422
Risk Factors for the Rising Rates of Primary Liver Cancer in the United States
El-Serag, H. B., & Mason, A. C. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.21.3227 · Cited by 418
Self-citationEarly detection of hepatocellular carcinoma increases the chance of treatment: Hong Kong experience
Yuen, M.-F., Cheng, C.-C., Lauder, I. J., Lam, S.-K., Ooi, C. G., & Lai, C.-L. (2000) · Hepatology · doi:10.1002/hep.510310211 · Cited by 411
Assessing Comorbidity Using Claims Data: An Overview
Klabunde, C. N., Warren, J. L., & Legler, J. M. (2002) · Medical Care · doi:10.1097/00005650-200208001-00004 · Cited by 382
Performing likelihood ratio tests with multiply-imputed data sets
MENG, X.-L., & RUBIN, D. B. (1992) · Biometrika · doi:10.1093/biomet/79.1.103 · Cited by 366
Trevisani, F. (2002) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(01)04119-3 · Cited by 313
KRAMER, J. R., DAVILA, J. A., MILLER, E. D., RICHARDSON, P., GIORDANO, T. P., & EL‐SERAG, H. B. (2008) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2007.03572.x · Cited by 268
Self-citationEl-Serag, H. B., Siegel, A. B., Davila, J. A., Shaib, Y. H., Cayton-Woody, M., McBride, R., & McGlynn, K. A. (2006) · Journal of Hepatology · doi:10.1016/j.jhep.2005.10.002 · Cited by 232
Self-citationTong, M. J., Blatt, L. M., & Kao, V. W. C. (2001) · Journal of Gastroenterology and Hepatology · doi:10.1046/j.1440-1746.2001.02470.x · Cited by 156
Improved survival with screening for hepatocellular carcinoma
Wong, L. L., Limm, W., Severino, R., & Wong, L. M. (2000) · Liver Transplantation · doi:10.1053/lv.2000.4875 · Cited by 143
Screening for Hepatocellular Carcinoma in Patients With Advanced Cirrhosis
Chalasani, N., Horlander, J. C., Said, A. T., et al. (1999) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.1999.01448.x · Cited by 132
Hassan, M. M., Frome, A., Patt, Y. Z., et al. (2002) · Journal of Clinical Gastroenterology · doi:10.1097/00004836-200209000-00013 · Cited by 130
Trevisani, F., Cantarini, M. C., Labate, A. M. M., Notariis, S. D., Rapaccini, G., Farinati, F., Poggio, P. D., Nolfo, M. A. D., Benvegnù, L., Zoli, M., et al. (2004) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2004.30137.x · Cited by 128
Prospective study of early detection for primary liver cancer
Yang, B., Zhang, B., Xu, Y., Wang, W., Shen, Y.-F., Zhang, A. R., & Zhong, X. (1997) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/bf01438313 · Cited by 127
Trevisani, F., Santi, V., Gramenzi, A., Nolfo, M. A. D., Poggio, P. D., Benvegnù, L., Rapaccini, G., Farinati, F., Zoli, M., Borzio, F., et al. (2007) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2007.01395.x · Cited by 114
Utilization of Screening for Hepatocellular Carcinoma in the United States
Davila, J. A., Weston, A., Smalley, W. E., & El‐Serag, H. B. (2007) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0b013e3180381560 · Cited by 113
Self-citationMortality and Hospital Utilization for Hepatocellular Carcinoma in the United States
Kim, W. R., Gores, G. J., BENSON, J., Therneau, T. M., & MELTONIII, L. (2005) · Gastroenterology · doi:10.1016/j.gastro.2005.05.001 · Cited by 106
Screening for Hepatocellular Carcinoma
Nguyen, M. H., & Keeffe, E. B. (2002) · Journal of Clinical Gastroenterology · doi:10.1097/00004836-200211002-00004 · Cited by 91
Leykum, L. K., El‐Serag, H. B., Cornell, J. E., & Papadopoulos, K. P. (2007) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2007.01.014 · Cited by 71
Self-citationWorkshop on Screening for Hepatocellular Carcinoma
McMahon, B. J., & London, T. W. (1991) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/83.13.916 · Cited by 69
Is female sex a significant favorable prognostic factor in hepatocellular carcinoma?
Farinati, F., Sergio, A., Giacomin, A., Nolfo, M. A. D., Poggio, P. D., Benvegnù, L., Rapaccini, G., Zoli, M., Borzio, F., Giannini, E. G., et al. (2009) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0b013e32831a86f8 · Cited by 60
Yu, E. W.-R., Chie, W., & Chen, T. H.-H. (2004) · The Cancer Journal · doi:10.1097/00130404-200409000-00009 · Cited by 52
Screening for hepatocellular carcinoma
Sherman, M. (2005) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2004.11.006 · Cited by 49
Imputation of Binary Treatment Variables With Measurement Error in Administrative Data
Yucel, R. M., & Zaslavsky, A. M. (2005) · Journal of the American Statistical Association · doi:10.1198/016214505000000754 · Cited by 38
Zheng, H., Yucel, R. M., Ayanian, J. Z., & Zaslavsky, A. M. (2005) · Medical Care · doi:10.1097/01.mlr.0000188910.88374.11 · Cited by 24
Cited by
El-Serag, H. B. (2011) · New England Journal of Medicine · doi:10.1056/nejmra1001683 · Cited by 3,529
Self-citationSingal, A. G., Pillai, A., & Tiro, J. (2014) · PLoS Medicine · doi:10.1371/journal.pmed.1001624 · Cited by 817
Targeted Therapies for Hepatocellular Carcinoma
Villanueva, A., & Llovet, J. M. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.03.006 · Cited by 449
Hepatocellular carcinoma in the setting of alcohol-related liver disease
Ganne-Carrié, N., & Nahon, P. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2018.10.008 · Cited by 360
Wolf, E., Rich, N. E., Marrero, J. A., Parikh, N. D., & Singal, A. G. (2021) · Hepatology · doi:10.1002/hep.31309 · Cited by 333
Metadata
- Authors
- Davila, J. A., Morgan, R. O., Richardson, P. A., Du, X. L., McGlynn, K. A., & El-Serag, H. B.
- Venue
- Hepatology
- Published
- 2010-07
- Volume
- 52
- Issue
- 1
- Pages
- 132-141
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W2128795237
- Cited by
- 392
- References
- 34
- FWCI
- 16.75
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.